Shares of Clover Health Investments, Corp. (NASDAQ:CLOV – Get Free Report) gapped down before the market opened on Thursday . The stock had previously closed at $4.35, but opened at $3.89. Clover Health Investments shares last traded at $3.48, with a volume of 8,369,665 shares changing hands.
Analyst Upgrades and Downgrades
Separately, UBS Group started coverage on shares of Clover Health Investments in a report on Monday, October 7th. They set a “neutral” rating and a $4.00 target price on the stock.
View Our Latest Research Report on Clover Health Investments
Clover Health Investments Trading Down 16.1 %
Clover Health Investments (NASDAQ:CLOV – Get Free Report) last issued its earnings results on Monday, August 5th. The company reported $0.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.05. The business had revenue of $356.26 million for the quarter, compared to analysts’ expectations of $338.70 million. Clover Health Investments had a negative net margin of 7.30% and a negative return on equity of 36.55%. During the same quarter in the previous year, the firm posted ($0.06) EPS. As a group, research analysts expect that Clover Health Investments, Corp. will post -0.13 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in CLOV. XTX Topco Ltd bought a new position in shares of Clover Health Investments in the second quarter worth $932,000. Jupiter Asset Management Ltd. increased its holdings in shares of Clover Health Investments by 18.1% in the first quarter. Jupiter Asset Management Ltd. now owns 4,525,079 shares of the company’s stock worth $3,593,000 after purchasing an additional 692,878 shares during the period. Choreo LLC bought a new position in shares of Clover Health Investments in the second quarter worth $344,000. Squarepoint Ops LLC increased its holdings in shares of Clover Health Investments by 220.7% in the second quarter. Squarepoint Ops LLC now owns 130,352 shares of the company’s stock worth $160,000 after purchasing an additional 238,329 shares during the period. Finally, Bayesian Capital Management LP bought a new position in shares of Clover Health Investments in the first quarter worth $142,000. Institutional investors own 19.77% of the company’s stock.
About Clover Health Investments
Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.
See Also
- Five stocks we like better than Clover Health Investments
- Stock Average Calculator
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Energy and Oil Stocks Explained
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Clover Health Investments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clover Health Investments and related companies with MarketBeat.com's FREE daily email newsletter.